Boston Scientific Corporation has announced a significant milestone for its telemonitoring technology with the initial use of the Latitude NXT Remote Patient Management System for pacemaker patients in Europe.
It’s all pretty simple in essence. At the patient end the company’s website and patient communicator merge key features from the trusted Latitude system with new features requested by physicians and patients. The result, according to Boston Scientific is a simplified experience with wireless and automatic remote follow-up and optional integrated cellular GSM connectivity.
The system is fully compatible with Boston Scientific’s advanced pacemaker family: INGENIO™ and ADVANTIO™ pacemakers and INVIVE™ cardiac resynchronization therapy pacemakers (CRT-P).
In addition, Latitude NXT cleverly features a unique communicator-initiated device interrogation which is designed to minimise impact on implanted device battery longevity, potentially giving patients greater peace of mind.
So, the overall picture is of a system that provides convenient online access to relevant pacemaker patient information, and flexibility and control in how clinicians receive and review data. The system features alert notification options such as SMS message or email, simple website administration, and integration with the hospital medical database (electronic medical records, or EMR) to automate hospital workflow — which could save up to 15 minutes for each patient transmission, the average time it takes to manually enter routine device follow-up data into an EMR system.
Furthermore Latitude NXT is compatible with the wireless weight scale and blood pressure monitor from Boston Scientific, meaning physicians can choose to remotely monitor a series of relevant health status indicators including weight and blood pressure, as well as respiratory and sleep apnea trending.
By providing access to this diagnostic information, Boston claims its Latitude NXT system enables physicians to risk-stratify patients to more confidently make informed, proactive treatment decisions, so it will be interesting to see whether its target audience agrees as it goes into real-world European roll-out phase.
Dr. Roberto Verlato, head of cardiology at Camposampiero Hospital in Verona, Italy, kicked things off with a patient implanted with an Ingenio™ SR pacemaker, and provided the patient with a new home-based wireless communicator. Dr Verlato said, “We welcome the next-generation LATITUDE NXT system as it provides pacemaker patients with a simple and easy-to-use communicator that may replace certain in-clinic follow-up visits. The system offers clinicians the most comprehensive suite of diagnostic tools in the CRM industry to support proactive treatment decisions and provide an opportunity to verify improvement of clinical outcomes, as was demonstrated for ICD and CRT-D patients in the ALTITUDE Survival study.”
“We are proud to enhance the level of support available to pacemaker patients by offering the state-of-the-art Latitude NXT system. An increasing percentage of patients needing cardiac rhythm therapy are indicated for pacemakers, and we are pleased to continue to innovate technology to support positive patient outcomes and quality of life,” said Michael Onuscheck, senior vice president and president of EMEA for Boston Scientific.
The Latitude NXT Remote Patient Management System is currently under review by the U.S. Food and Drug Administration and is currently not available for sale in the United States.
Source: Boston Scientific